Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
Lesley‐Ann Martin(Institute of Cancer Research), Mitch Dowsett(Royal Marsden NHS Foundation Trust)
Cited by 33
Related Papers
Deficits in plasma oestradiol measurement in studies and management of breast cancer
|Breast Cancer Research|2004|82
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
|Breast Cancer Research|2012|43